Telephone sharing button Contact Us linkedin sharing button Share wechat sharing button Share wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Viral Product Process Development

WuXi Biologics’ HEK 293 Cells

 

 

Virus Production Cell Line in Development

Cell Culture Process Development

 

  • Multiple cell culture modes

 

    • Batch, fed-batch or perfusion

     

  • Flexible cell culture format 

 

    • Adherent cell culture (Cell Factory/ cellSTAK, iCellis fixed-bed bioreactor) and microcarrier-based adherent cell culture
    • Suspension cell culture (Bioreactor)

     

  • Commercial media and chemically defined media preferredProcess Platform for Virus Production

Purification Process Development

 

  • Early stage feasibility study
  • Process development towards IND filing
  • Late stage process geared-characterization

 

Purification Process Development


Innovations To Increase Virus Titer

Suspension Cell Culture
  • Intensified cell culture process using perfusion (ATF-based), to increase  cell density  2–5 fold
  • N-1 perfusion in wave system to reduce total cell expansion and overall roduction timelines
  • Cell culture scaling-up from bench scale to 200 L, and up to 2,000 L 
Adherent Cell Culture
  • Perfusion-based microcarrier cell culture in single-use bioreactors increase titers efficiently than a typical cell factory
  • Fixed-bed bioreactor, (e.g., iCellis), to greatly increase volumetric titer